Reaction Details Report a problem with these data
Target
Cyclin-dependent kinase 2
Ligand
BDBM236557
Substrate
n/a
Meas. Tech.
Mobility Shift Assay
pH
7.5±n/a
Temperature
301.15±n/a K
IC50
>10000±n/a nM
Comments
extracted
Citation
 Wu, F; Shu, C PI3K and/or mTOR inhibitor US Patent  US9365572 Publication Date 6/14/2016 
Target
Name:
Cyclin-dependent kinase 2
Synonyms:
CDK2 | CDK2-Kinase | CDK2_HUMAN | CDKN2 | Cell division protein kinase 2 | Cyclin-dependent kinase 2 (CDK2) | Protein cereblon/Cyclin-dependent kinase 2 | p33 protein kinase
Type:
Enzyme Subunit
Mol. Mass.:
33938.17
Organism:
Homo sapiens (Human)
Description:
P24941
Residue:
298
Sequence:
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
  
Inhibitor
Name:
BDBM236557
Synonyms:
US9365572, 5
Type:
Small organic molecule
Emp. Form.:
C22H13F3N6O2
Mol. Mass.:
450.3728
SMILES:
Nc1ccc(cn1)-c1ccc2ncc3c(n(-c4cccc(c4)C(F)(F)F)c(=O)[nH]c3=O)c2n1
Structure:
Search PDB for entries with ligand similarity: